Funding
Ongoing Support
- NIH K01DK120737 (PI: Saloman) 2019-2024 Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?
- NIH R01DK450698 (PI: Gittes) 2019-2024 Chemical pancreatectomy for chronic pancreatitis and pancreatic cancer.
- NIH R01DK127042 (PI: Phillips) 2021-2026 P-QST Project: Pancreatic Quantitative Sensory Testing to Predict Treatment Response for Pain in Chronic Pancreatitis
-
PanCan 22-20-SALO (PI: Saloman) 2022-2024 Neuronal checkpoint Signaling in Pancreas Cancer Pain
-
NIH R01DK136478 (PI: Steen and Saloman) 2023-2027 Biomarkers to stratify pain severity and type in pancreatic disease
- NIH R01NS131165 (PI: Khanna) 2023-2026 Validation of Neuropilin-1 receptor signaling in nociceptive processing
- NIH R01DK138809 (PI: Bellin and Steen) 2023-2027 Protein biomarkers to predict pain outcomes after total pancreatectomy with islet autotransplant
Recently Completed Support
- Western Pennsylvania Chapter of National Pancreas Foundation (PI: Saloman) 2022 Urine Biomarkers of Pancreatitis Pain
- Cygnal Therapeutics (PI: Saloman) 2021-2022 Neuronal Transcriptome in Pancreas Cancer
- NIH R21DK122293 (PI: Saloman) 2020-2023 Mechanism-based Approach to Pain in Chronic Pancreatitis
- UPMC Hillman Cancer Center (PI: Davis and Vignali) 2019-2021 Neuronally-mediated suppression of the immune system promotes pancreas cancer
- Hirshberg Foundation (PI: Saloman) 2016-2018 Neural Regulation of Pancreatic Cancer